BioInvent Interim Report January 1 – March 31, 2019
LUND, Sweden, May 22, 2019 /PRNewswire/ — Net sales SEK 17.4 (11.3) million Earnings after tax SEK -27.8 (-24.9) million Earnings after tax per share before and after dilution: SEK -0.08 (-0.08) SEK Liquid funds as of March 31, 2019 SEK 28.5* (108.2) million. Cash flow from operating…
View more at https://www.prnewswire.com:443/news-releases/bioinvent-interim-report-january-1–march-31-2019-300854853.html
Comments Off on BioInvent Interim Report January 1 – March 31, 2019